in Newswire February 19, 2020

Class Action Claims Walgreens Sold NDMA-, NDEA-Contaminated Valsartan to Illinois Consumers

Shanov v. Walgreens Boots Alliance, Inc. et al.

Filed: February 14, 2020 § 2020CH01884

A class action alleges Walgreens sold contaminated valsartan to Illinois consumers without disclosing the drug was tainted by NDMA and/or NDEA.




Last Updated on February 19, 2020 — 2:50 PM

Corrado Rizzi

Corrado Rizzi is the Managing Editor and a writer for

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.